ENTITY
Shire PLC

Shire PLC (SHP LN)

38
Analysis
Health Care • Ireland
SHIRE PLC is a global biotechnology group focused on serving people with rare diseases and other specialized conditions. The Company develops products across core therapeutic areas including hematology, immunology, neuroscience, ophthalmics, lysosomal storage disorders, gastrointestinal, internal medicine endocrine and hereditary angioedema, and in oncology.
more
•09 Apr 2018 01:03

The Week That Was In North Asia@Smartkarma: JDI, Renesas, Trade, Governance, and Mobis/Glovis

It was a "slow" week on Smartkarma with 'only' 165 pieces of research published, but it is school vacation week in Asia, with two days off in Hong...

Logo
253 Views
Share
•02 Apr 2018 13:47

Takeda + Shire - Highly Accretive Merger Considering Takeda’s Core Earnings

Announcement – Takeda, on March 28, 2018, confirmed that it is officially considering making an offer for Shire (NASDAQ: SHPG) and that it has time...

•02 Apr 2018 02:16

Takeda Considers Swallowing Shire, a Somewhat Surprising Move That Could Make Strategic Sense

Japanese pharma firm Takeda Pharmaceutical Co Ltd (4502 JP) said it is officially considering making an offer for diversified rare-disease-focused...

Share
bullish•CSL Ltd
•10 Oct 2017 01:55

Not All Players Are Equal in the Plasma Industry

According to Allied Market Research, the IVIG (intravenous IG) market was valued at US$7.86bn and is expected to reach US$12.36bn by 2022. IVIG is...

•27 Aug 2017 10:04

Chugai Pharmaceutical (4519 JP): Emicizumab Gets PDUFA Data

Chugai Pharmaceutical (4519 JP) announced on August 24th that the US FDA has accepted its Biologics License Application (BLA) for emicizumab (emi)...

x